E Fund Management Co., Ltd. Apellis Pharmaceuticals, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.8 Billion
- Q2 2024
A detailed history of E Fund Management Co., Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 14,696 shares of APLS stock, worth $418,542. This represents 0.03% of its overall portfolio holdings.
Number of Shares
14,696
Previous 7,032
108.99%
Holding current value
$418,542
Previous $413,000
36.32%
% of portfolio
0.03%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$467 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$331 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$316 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$279 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$165 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.13B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...